Answers are grounded in this paper and cite their sources.
• BRAF V600E mutation and Mcl-1 expression. • Implications for treatment. • Need for targeted adjuvant therapies.
No takes yet. Share an insight, caveat, or question.
Santana et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: